| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.5 | 0.004 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.49 | 0.2 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.4 | 0.04 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.35 | 0.08 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.32 | 0.1 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.28 | 0.4 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.27 | 0.1 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.27 | 0.1 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.24 | 0.2 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.1 |